Evidence map›Paper›PMID 31214192›Full record

ArticleFrontiers in immunology2019

The Intra-nuclear SphK2-S1P Axis Facilitates M1-to-M2 Shift of Microglia via Suppressing HDAC1-Mediated KLF4 Deacetylation.

Juan Ji, Juan Wang, Jin Yang, Xi-Peng Wang, Jing-Jing Huang, Teng-Fei Xue, Xiu-Lan Sun

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.

  1. Consequences of Aging on Bone.Aging and disease · 2023
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Juan JiDepartment of Pharmacology, Neuroprotective Drug Discovery Key Laboratory of Nanjing Medical University, Nanjing, China.
Juan WangDepartment of Pharmacology, Neuroprotective Drug Discovery Key Laboratory of Nanjing Medical University, Nanjing, China.
Jin YangDepartment of Pharmacology, Neuroprotective Drug Discovery Key Laboratory of Nanjing Medical University, Nanjing, China.
Xi-Peng WangDepartment of Pharmacology, Neuroprotective Drug Discovery Key Laboratory of Nanjing Medical University, Nanjing, China.
Jing-Jing HuangDepartment of Pharmacology, Neuroprotective Drug Discovery Key Laboratory of Nanjing Medical University, Nanjing, China.
Teng-Fei XueDepartment of Pharmacology, Neuroprotective Drug Discovery Key Laboratory of Nanjing Medical University, Nanjing, China.
Xiu-Lan SunDepartment of Pharmacology, Neuroprotective Drug Discovery Key Laboratory of Nanjing Medical University, Nanjing, China.
Nanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sphingosine 1-phosphate (S1P) is involved in a variety of cellular responses including microglial activation and polarization. However, the impacts of S1P on ischemia-induced microglial activation and polarization remain unclear. In the present study, Sprague-Dawley rats were selected for middle cerebral artery occlusion (MCAO) establishment and treated with S1P analog FTY720 (0.5, 1, 2 mg/kg) for 24 h. The impacts of FTY720 on oxygen-glucose deprivation (OGD)-induced microglial polarization were examined in the primary cultured microglia. FTY720 treatment could prevent ischemia-induced brain injury and neurological dysfunction, also decrease the levels of IL-1β and TNF-α and promote M2 microglial polarization in rats. Further, we found that FTY720 inhibited the expressions of M1 markers, but increased the expressions of M2 markers in the OGD-insulted microglia. And FTY720 could enhance the phagocytic function of microglia. The sphingosine kinase 1/2 (SphK1/2) or the Sphk2 inhibitor could prevent the M1 to M2 phenotype shift improved by FTY720, but the Sphk1 inhibitor failed to affect the roles of FTY720. Furthermore, the Sphk1/2 or Sphk2 inhibitor promoted the activities of histone deacetylase (HDAC1) and inhibited the histone acetylation of the Krüppel-like factor 4 (KLF4) promoter regions, indicating that intra-nuclear pFTY720 inhibited HDAC1 activations and prevented KLF4 to interact with HDAC1, and thereby suppresses KLF4 deacetylation. Therefore, our data reveals that intra-nuclear SphK2-S1P axis might facilitate the transformation of microglial polarization from M1 to M2 phenotype, which might be intra-nuclear regulatory mechanisms of FTY720-prevented neuroinflammation.

Indexed as

Signal TransductionAcetylationAnimalsBrain InjuriesCell PlasticityCells, CulturedFingolimod HydrochlorideGlucoseHistone Deacetylase 1Inflammation MediatorsKruppel-Like Factor 4Kruppel-Like Transcription FactorsLysophospholipidsMicrogliaOxidation-ReductionOxygenFingolimod HydrochlorideGlucoseHistone Deacetylase 1Inflammation MediatorsKlf4 protein, ratKruppel-Like Factor 4Kruppel-Like Transcription FactorsLysophospholipidsOxygenPhosphotransferases (Alcohol Group Acceptor)RNA, Small InterferingSphingosinesphingosine 1-phosphateischemiaKLF4microglial polarizationS1PSphk2

Identifiers

PMID31214192
PMCPMC6557990
OpenAlexW2948346504

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.